Jonathan Lin, Jaymie Oentoro, Christina Anna Giordano, Jacob Rocha, Tahmeena Ahmed, Pons Materum, Leah J Gallagher, Paula Fernicola, Roxana M Ponce, Htien Lee, Cynthia Poerio, Carlos A Tirado
{"title":"An Abnormal Clone with a der(12;22)(q10;q10) as a Rare Abnormality Within the Context of dup(1)(q25q43), Deletion of ABL1 and a t(8;21) in a Pediatric Male Patient with Acute Myeloid Leukemia.","authors":"Jonathan Lin, Jaymie Oentoro, Christina Anna Giordano, Jacob Rocha, Tahmeena Ahmed, Pons Materum, Leah J Gallagher, Paula Fernicola, Roxana M Ponce, Htien Lee, Cynthia Poerio, Carlos A Tirado","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>We describe a case of a 13-year-old male who presented with fatigue, loss of appetite, and weakness. Flow cytometric analysis of the bone marrow aspirate demonstrated an abnormal population of myeloid blasts, comprising approximately 48% of total events, suggesting acute myeloid leukemia (AML). The cells express CD45(dim+), CD34(+), CD117(+), CD33(+), CD13(dim+), HLADR(+), CD38(+), CD123(weak+), CD11b(weak+), CD15(dim+), CD64(variable+), CD14(weak+), CD4(dim+), CD56(variable+), CD7(weak+), CD11c(+), CD65(dim+), CD9(-), and MPO(+) suggesting acute myeloid leukemia. This particular pattern with a t(8;21) is seen in 15-18% of AML cases. Although it's in the favorable risk stratification category (NCCN Clinical Practice Guidelines 2023), the presence of complex abnormalities, including 1q+, deletion of 12p, and a der(12;22), suggests genomic instability and poor prognosis. The patient died six months post-transplant.</p>","PeriodicalId":73975,"journal":{"name":"Journal of the Association of Genetic Technologists","volume":"52 2","pages":"40-44"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148195315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Chronic Myelomonocytic Leukemia (CMML) with Novel t(1;3)(p36.2;p12): Dual-locus Genomic Disruption Associated with Early Mortality.","authors":"Pina J Trivedi, Nidhi Patel, Jigna Joshi, Rashmi Oza","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>Chronic myelomonocytic leukemia (CMML) is defined as a clonal disorder of the myeloid cell lineage, with the characteristic feature being monocytosis. Chromosomal abnormalities are common, but translocations involving chromosome 1p36 are rare. Here, we document a case of CMML that carried an unreported translocation involving t(1;3)(p36.2;p12). The patient showed rapid progression and died within six days post-diagnosis. The 1p36.2 chromosomal region harbors tumor suppressors such as PR domain containing 16 (PRDM16), Tumor Protein 73 (TP73), Cadherin 5 or VE-cadherin (CHD5), and Kinase Family Member 1B (KIF1B), while the 3p12 chromosomal location plays a role in the malignant transformation and disruption of the tumor suppressors, focusing on the genomic instability observed in the case. These changes may partially harbor the capacity to contribute to the pathogenesis of aggressive behaviors in leukemia through failure of apoptosis, chromatin remodeling pathways, and enhanced self-renewal capabilities of stem cells.</p>","PeriodicalId":73975,"journal":{"name":"Journal of the Association of Genetic Technologists","volume":"52 2","pages":"45-49"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148195281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dori Chau, Jaymie Oentoro, Jacob Rocha, Christina Giordano, Tahmeena Ahmed, Carlos A Tirado
{"title":"A Highly Abnormal Clone in a Pediatric Patient with B-Lymphoblastic Leukemia.","authors":"Dori Chau, Jaymie Oentoro, Jacob Rocha, Christina Giordano, Tahmeena Ahmed, Carlos A Tirado","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>We present a case of a 14-year-old male who presented with loss of appetite, nosebleeds, and fatigue. He visited the clinic, and bone marrow studies were suggested. Bone marrow, core biopsy and clot section showed hypercellularity (80-90%) with sheets of blasts with suspicion of precursor B acute lymphoblastic leukemia (B-ALL). Chromosome analysis of 20 trypsin-Giemsa banded metaphase spreads showed an abnormal male composite karyotype described as 45~47,XY,+1,add(1)(p13),add(1)(q10),add(7)(q36), add(12)(q24.1),der(12)(p13->q24.1::12p13.2->12p13.1::12q24.1->12qter),-13,-15,add(16)(p13.1),-17,+1~3 mar[cp17]/46,XY[3]. Fluorescence in situ hybridization (FISH) was performed, showing one diminished signal for ETV6 in 99% [198/200] of the nuclei examined with the ETV6/RUNX1 probe. ETV6 break-apart probe on interphase nuclei showed one fusion (normal) and one green signal (5'ETV6) in 92% [184/200] of the nuclei. Metaphase FISH with the ETV6 BA probe showed one fusion on the normal chromosome 12 and one green signal (5'ETV6) on the long arm of the derivative chromosome 12. Additionally, metaphase FISH showed a 1q25 signal (green) in one abnormal copy of chromosome 1 as well as 1p36 signal (orange) in the additional abnormal copy of chromosome 1, and a retinoblastoma (Rb) signal (13q14.2) on the derivative chromosome 7. In light of these studies, the karyotype was described as a highly complex karyotype associated with genomic instability and a poor prognosis.</p>","PeriodicalId":73975,"journal":{"name":"Journal of the Association of Genetic Technologists","volume":"52 3","pages":"84-90"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148901755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Coexistence of Dual Chromosomal Abnormalities t(3;7) and t(9;22) in Case of B-Acute Lymphoblastic Leukemia: a Rare Genomic Profile with Diagnostic and Prognostic Challenges.","authors":"Pina J Trivedi, Nidhi Patel, Krishna Barad, Rashmi Oza","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>Acute lymphocytic leukemia (ALL) is a hematologic malignancy marked by clonal growth of lymphoid precursors within the bone marrow, resulting in disrupted hematopoiesis. Chromosomal abnormalities provide valuable information on the development of ALL and serve as a key indicator of patient outcomes and treatment strategies. Numerous genetic abnormalities can be seen in ALL. Here, we described a case of a 15-year-old patient with B-ALL confirmed through biopsy and immunophenotyping. Conventional cytogenetic and FISH analysis showed t(3;7) with the presence of t(9;22). Translocation t(3;7) is rarely observed and is associated with a worse/ poor prognosis. Hence, the identification of such translocations in patients with B-ALL can aid in patient stratification, personalized medicine, and risk assessment.</p>","PeriodicalId":73975,"journal":{"name":"Journal of the Association of Genetic Technologists","volume":"52 1","pages":"17-21"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147322714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asmaa El Desoky, Ella Ansell, Joanna L Conant, Katherine Devitt, Juli-Anne Gardner
{"title":"The Many Classifications of Acute Myeloid Leukemia with Dysplasia: WHO vs ICC.","authors":"Asmaa El Desoky, Ella Ansell, Joanna L Conant, Katherine Devitt, Juli-Anne Gardner","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>Acute erythroid leukemia (AEL), a rare and diagnostically complex subtype of acute leukemia, has undergone significant evolution in its diagnostic criteria since its initial description in 1912 by Copelli. Proper classification requires the integration of clinical history and diagnostic studies, including peripheral blood and bone marrow morphology, flow cytometry, cytogenetic and molecular studies. The latter have significant clinical and prognostic implications. Here, we discuss a case of AEL with a TP53 mutation and highlight the importance of integration of multiple test modalities in the accurate diagnosis of AEL versus acute myeloid leukemia, myelodysplasia- related (AML-MR). Additionally, we provide an overview of AEL and compare diagnostic changes in the WHO-HAEM5 and ICC.</p>","PeriodicalId":73975,"journal":{"name":"Journal of the Association of Genetic Technologists","volume":"52 1","pages":"4-10"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147322728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amanda S Openshaw, Rachel M Lasher, Michelle Q Bosworth, Danielle LaGrave, Hiba Risheg, Bo Hong
{"title":"Laboratory Stewardship Rescues Misordered Familial Targeted Cytogenetic Testing Following Proband Genomic Testing: Case Series Review.","authors":"Amanda S Openshaw, Rachel M Lasher, Michelle Q Bosworth, Danielle LaGrave, Hiba Risheg, Bo Hong","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>Laboratory genetic counselors (GCs) in cytogenetics oversee a laboratory stewardship (LS) program to review the appropriateness of incoming test orders, which saves both time and healthcare resources. This is especially important for familial cytogenetic testing performed after proband genomic testing, since appropriate testing methodology may vary between families and among family members. We describe three inappropriate orders for familial cytogenetic testing performed after proband genomic testing that were identified and corrected because of the LS process at ARUP Laboratories. Review of familial testing using an LS program avoids false-negative results in at-risk relatives and shortens the time to provide accurate results, enabling relatives to make informed clinical management decisions. This series highlights the importance of seeking genetic advice prior to submitting familial testing samples and including the proband's test results to help the laboratory confirm the appropriateness of test orders. Structural variants (SVs) are identified by proband chromosome analysis, genomic microarray (GMA), and genome sequencing. Healthcare providers without specialized genetics expertise may not realize that SVs can be cryptic by karyotype or undetectable by GMA (when balanced), and that standard FISH probes may fail to detect SVs due to FISH probe localization not spanning the abnormality, even when the FISH probe is designed to target the patient's condition. This series illustrates the benefits of a routine laboratory LS program for familial cytogenetic testing, particularly when cryptic SVs are involved.</p>","PeriodicalId":73975,"journal":{"name":"Journal of the Association of Genetic Technologists","volume":"52 2","pages":"56-60"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148195335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Integrated Cytogenetic and FISH Profiling Reveals inv(16) Dominance and Cryptic 11q23 Lesions in AML and ALL: Clinical Significance from a Referral Cohort.","authors":"Pina J Trivedi, Krishna Barad, Nidhi Patel, Rashmi Oza","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>Cytogenetic abnormalities play a pivotal role in the diagnosis, classification, risk stratification, and therapeutic decision-making in hematological malignancies. Among these, acute leukemia represents a genetically heterogeneous group in which chromosomal rearrangements and copy number changes significantly influence disease behavior and outcome. The present study describes a comprehensive cytogenetic and fluorescence in situ hybridization (FISH) analysis of 22 patients diagnosed with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic myeloid leukemia (CML) in blast crisis. Conventional karyotyping and targeted FISH probes were employed to identify recurrent and rare chromosomal abnormalities, with a special emphasis on inv(16) (p13.1q22), MLL rearrangements, and complex karyotypes. Our findings highlight the indispensable role of integrating cytogenetics and FISH in routine diagnostic workflows, especially in cases with cryptic rearrangements or subclonal abnormalities, thereby underscoring their clinical and prognostic significance.</p>","PeriodicalId":73975,"journal":{"name":"Journal of the Association of Genetic Technologists","volume":"52 2","pages":"50-55"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148195349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cytogenetic Evaluation of APL Cases Using Karyotyping and FISH and Its Correlation with Overall Clinical Outcomes: A Retrospective Laboratory-Based Study.","authors":"Pina J Trivedi, Krishna Barad, Nidhi Patel, Rashmi Oza","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>Acute promyelocytic leukemia (APL) is cytogenetically characterized by the t(15;17)(q22;q21) translocation generating the PML::RARA fusion gene. Accurate laboratory diagnosis is essential for disease confirmation and prognostic prediction. In our cytogenetics laboratory, conventional GTG-banded karyotyping and fluorescence in situ hybridization (FISH) are routinely performed for all APL-suspected cases received from the chemotherapy unit of The Gujarat Cancer and Research Institute, Ahmedabad, after bone marrow/IPT requisitions. To document the cytogenetic abnormalities detected in APL-suspected cases using karyotyping and FISH, and to analyze their association with overall patient survival outcomes. This retrospective study included 32 APL-suspected cases referred to our laboratory. Each case underwent conventional cytogenetic analysis and FISH for the PML::RARA fusion. Clinical outcomes (Normal/Recovered, Discharged/Stable, Expired) were obtained from hospital records solely for correlation. Statistical analysis using SPSS included cross-tabulation and chi-square testing to assess the association between FISH status and patient outcomes. FISH detected PML::RARA fusion in 78.1% of cases (25/32), while 21.9% (7/32) exhibited negative or variant fusion patterns. All successful karyotyping studies demonstrated t(15;17), with occasional additional abnormalities. FISH-positive patients showed significantly better recovery rates (60%) compared to none among FISH-negative/variant cases. The association between FISH status and outcome was statistically significant (χ² = 11.165, p = 0.004). Cytogenetic evaluation using karyotyping and FISH provides essential diagnostic and prognostic insight in APL-suspected cases. FISH positivity strongly correlates with favorable outcomes, underscoring its value in routine diagnostic workflows.</p>","PeriodicalId":73975,"journal":{"name":"Journal of the Association of Genetic Technologists","volume":"52 1","pages":"11-16"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147322693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Rare t(1;11)(q42;q23) Rearrangement with Trisomy 8 and Trisomy 21 in a Pediatric Acute Myeloid Leukemia Patient with Aberrant CD7 Expression and Jacob Syndrome: Diagnostic Value of Conventional Cytogenetics and Fluorescence in Situ Hybridization in a Rapidly Fatal Case.","authors":"Pina J Trivedi, Nidhi Patel, Jigna Joshi, Rashmi Oza","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>Acute myeloid leukemia (AML) with KMT2A gene rearrangements has been observed to demonstrate an aggressive biological behavior, especially in pediatric cases. Cytogenetic abnormalities that are extremely uncommon, such as t(1;11)(q21;q23), in addition to other chromosomal abnormalities, can further impact the clinical course of the disease. The aim of the study is to report on an uncommon case of pediatric AML with a t(1;11)(q42;q23) involving a KMT2A gene rearrangement together with other chromosomal abnormalities, emphasizing the importance of performing cytogenetics and FISH studies for hematopoietic workups and an accurate diagnosis. Cytogenetic evaluation was done using conventional karyotype analysis. FISH studies using the KMT2A break-apart probe were used to establish the existence of gene rearrangement. To determine the partner chromosome, whole chromosome FISH painting was performed. Immunophenotypic studies were also performed to determine antigen expression. A two-year-old child diagnosed with AML had multiple chromosomal abnormalities, including t(1;11)(q42;q23), trisomy 8, trisomy 21, and 47,XYYc karyotype. There were four fusion signals for KMT2A obtained from FISH studies with two presenton chromosome 1. Whole chromosome painting provided confirmation for these results. Abnormal expression of CD7 antigen was demonstrated through immunophenotypic evaluation and indicated a poor prognosis. This case study shows that AML with a KMT2A gene rearrangement is associated with an aggressive clinical course and uncommon cytogenetics. It emphasizes the need to use FISH and cytogenetics together for the detection of gene fusions, partner chromosomes, and other cytogenetic aberrations.</p>","PeriodicalId":73975,"journal":{"name":"Journal of the Association of Genetic Technologists","volume":"52 3","pages":"80-83"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148901703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yu Sonia, Oentoro Jaymie, Guin Rohini, Carlos Tirado, Ahmed Tahmeena
{"title":"A Case of Synchronous Primary Pancreatic DLBCL and Incipient CML.","authors":"Yu Sonia, Oentoro Jaymie, Guin Rohini, Carlos Tirado, Ahmed Tahmeena","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>A 75-year-old male presented with back pain, abdominal discomfort, and weight loss, and was subsequently found to have a pancreatic head mass. Biopsy confirmed diffuse large B-cell lymphoma (DLBCL), and the patient achieved radiographic remission with chemotherapy. However, fluorescence in situ hybridization (FISH) analysis unexpectedly revealed Philadelphia chromosome-positive (Ph+) cells in the bone marrow and peripheral blood, establishing concurrent chronic myeloid leukemia (CML). Despite targeted therapy for CML, at last follow-up, the patient still has detectable BCR::ABL1. This rare case highlights the diagnostic importance of comprehensive staging and cytogenetic testing, as well as the therapeutic challenge of managing synchronous lymphoid and myeloid neoplasms.</p>","PeriodicalId":73975,"journal":{"name":"Journal of the Association of Genetic Technologists","volume":"51 4","pages":"176-179"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145835405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}